Neuromyelitis optica immunoglobulins as a marker of disease activity and response to therapy in patients with neuromyelitis optica

@article{WeinstockGuttman2008NeuromyelitisOI,
  title={Neuromyelitis optica immunoglobulins as a marker of disease activity and response to therapy in patients with neuromyelitis optica},
  author={Bianca Weinstock-Guttman and Colleen Miller and E Ann Yeh and Milena Sto{\vs}i{\'c} and Margaret Umhauer and Nehra Batra and Frederick E. Munschauer and Robert Zivadinov and Murali Ramanathan},
  journal={Multiple Sclerosis},
  year={2008},
  volume={14},
  pages={1061 - 1067}
}
Objective To determine whether neuromyelitis optica (NMO) immunoglobulin (IgG) antibody status in NMO/Devic’s disease patients followed prospectively is persistent or can change relative to the clinical status and/or response to therapy. Design A cross-sectional group of patients with NMO, relapsing extensive longitudinal transverse myelitis (RLETM) or optico-spinal multiple sclerosis (OSMS) were evaluated for the presence of NMO IgG antibodies. Repeated evaluation was made in all NMO/RLETM… CONTINUE READING

Figures, Tables, and Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 26 CITATIONS

Immune-mediated myelopathies.

VIEW 3 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

References

Publications referenced by this paper.
SHOWING 1-10 OF 19 REFERENCES